M-Health in Prostate Cancer: Professional and Patient Perspectives

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F24%3A00375867" target="_blank" >RIV/68407700:21460/24:00375867 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1007/978-3-031-61628-0_13" target="_blank" >http://dx.doi.org/10.1007/978-3-031-61628-0_13</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-3-031-61628-0_13" target="_blank" >10.1007/978-3-031-61628-0_13</a>

Jazyk výsledku

angličtina

Název v původním jazyce

M-Health in Prostate Cancer: Professional and Patient Perspectives

Popis výsledku v původním jazyce

In the current study, an analysis of mobile health (m-health) technology usage in managing prostate cancer, focusing on patients undergoing radiotherapy, was conducted. Amid increasing incidence and mortality rates of prostate cancer in the Czech Republic, exploring m-health potential in oncological care is of critical research interest. The aim was to identify the benefits of m-health in radiotherapy, assessing current market dynamics and stakeholder roles to inform the conceptualization of future m-health application development in oncology. A qualitative approach utilizing semi-structured interviews (using software MAXQDATA 22) with patients and medical staff was employed to gain deeper insights into personal experiences and preferences regarding m-health applications and devices. The analysis showed limited patient engagement with m-health technologies; some were interested in health monitoring, while others were worried about complexity and usability. Medical professionals recognized m-health’s potential in treatment optimization but noted integration and data security challenges. In conclusion, m-health represents significant potential for innovation in prostate cancer patient care. However, addressing existing challenges, including ensuring user-friendliness, effective integration into healthcare systems, and protecting personal health data, is imperative. These findings provide an overview of the current state and outline potential trajectories for future development and implementation of m-health in oncology.

Název v anglickém jazyce

M-Health in Prostate Cancer: Professional and Patient Perspectives

Popis výsledku anglicky

In the current study, an analysis of mobile health (m-health) technology usage in managing prostate cancer, focusing on patients undergoing radiotherapy, was conducted. Amid increasing incidence and mortality rates of prostate cancer in the Czech Republic, exploring m-health potential in oncological care is of critical research interest. The aim was to identify the benefits of m-health in radiotherapy, assessing current market dynamics and stakeholder roles to inform the conceptualization of future m-health application development in oncology. A qualitative approach utilizing semi-structured interviews (using software MAXQDATA 22) with patients and medical staff was employed to gain deeper insights into personal experiences and preferences regarding m-health applications and devices. The analysis showed limited patient engagement with m-health technologies; some were interested in health monitoring, while others were worried about complexity and usability. Medical professionals recognized m-health’s potential in treatment optimization but noted integration and data security challenges. In conclusion, m-health represents significant potential for innovation in prostate cancer patient care. However, addressing existing challenges, including ensuring user-friendliness, effective integration into healthcare systems, and protecting personal health data, is imperative. These findings provide an overview of the current state and outline potential trajectories for future development and implementation of m-health in oncology.

Druh

D - Stať ve sborníku

CEP obor

—

OECD FORD obor

30304 - Public and environmental health

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

9th European Medical and Biological Engineering Conference. Proceedings of EMBEC 2024

ISBN

978-3-031-61624-2

ISSN

1680-0737

e-ISSN

1433-9277

Počet stran výsledku

11

Strana od-do

111-121

Název nakladatele

Springer

Místo vydání

Wien

Místo konání akce

Portorož

Datum konání akce

9. 6. 2024

Typ akce podle státní příslušnosti

WRD - Celosvětová akce

Kód UT WoS článku

001313086700013